NRGSX | RFISX | NRGSX / RFISX | |
Total Expense Ratio | 0.74 | 1.15 | 64% |
Annual Report Gross Expense Ratio | 0.74 | 1.63 | 45% |
Fund Existence | 13 years | 14 years | - |
Gain YTD | -3.458 | -3.910 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.8B | 22M | 39,977% |
Annual Yield % from dividends | 0.06 | 0.00 | - |
Returns for 1 year | -7.18 | 0.29 | -2,498% |
Returns for 3 years | 9.33 | 11.50 | 81% |
Returns for 5 years | -1.44 | -10.10 | 14% |
Returns for 10 years | 10.14 | 4.87 | 208% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFMBX | 39.09 | 0.17 | +0.44% |
American Funds American Balanced F3 | |||
PRIAX | 35.03 | N/A | N/A |
Principal Glb Emerging Markets A | |||
CECYX | 30.38 | N/A | N/A |
Columbia Large Cap Enhanced Core Inst3 | |||
CVMAX | 22.22 | N/A | N/A |
Calvert Emerging Markets Equity A | |||
GMCUX | 16.99 | N/A | N/A |
Goldman Sachs Small/Mid Cap Equity R6 |